Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Pharm-country crawled date : 2021 - 08 - 19 save search
Alex Gorsky to Serve as Executive Chairman and Transition Role of Chief Executive Officer of Johnson & Johnson to Joaquin Duato, Effective January 3, 2022
Published: 2021-08-19 (Crawled : 23:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.32%
H: 1.53%
C: 1.1%
HES | News | $154.35 1.69% -3.11% 2.6M
|
Energy Minerals
|
| O: -2.46%
H: 1.49%
C: 0.7%
BioSig’s Signal Processing System for Arrhythmia Care To Be Featured At The Kansas City Heart Rhythm SymposiumA physician user from a leading medical center of excellence will present the technology and discuss recent clinical data
Published: 2021-08-19 (Crawled : 17:00) - biospace.com/
BSGM | $1.41 -8.44% -9.22% 200K
|
Health Technology
|
| O: -2.03%
H: 2.77%
C: -6.23%
heart technology symposium
BlueSphere Bio appoints industry veteran Jonathan Peacock
Published: 2021-08-19 (Crawled : 16:00) - biospace.com/
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.54%
H: 0.58%
C: 0.29%
Bristol Myers Squibb Receives European Commission Approval for Abecma (Idecabtagene Vicleucel), the First Anti-BCMA CAR T Cell Therapy for Relapsed and Refractory Multiple Myeloma
Published: 2021-08-19 (Crawled : 16:00) - biospace.com/
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: -0.41%
H: 2.16%
C: 1.27%
europe therapy approval car-t t-cell
NRx Pharmaceuticals Announces $30 Million Private Placement
Published: 2021-08-19 (Crawled : 16:00) - biospace.com/
NRXP 2 d | $3.08 1.99% 1.95% 230K
|
Manufacturing
|
| O: -21.09%
H: 9.27%
C: 7.45%
PaxMedica Selected by American Academy of Child and Adolescent Psychiatry (AACAP) to Present Data from its Recent Phase 2 Trial of PAX-101 (IV suramin) in Children with Autism Spectrum Disorder (ASD) in the Research Pipeline Program
Published: 2021-08-19 (Crawled : 13:00) - biospace.com/
PXMD | $0.7665 0.45% 0.44% 520K
|
Health Technology
| Email alert
Add to watchlist
phase 2 children research trial lsd
Janssen Presents Phase 1 Results for RYBREVANT™ (amivantamab-vmjw) in the Treatment of Patients with Advanced Non-Small Cell Lung Cancer with MET Exon 14 Skipping Mutations
Published: 2021-08-19 (Crawled : 13:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.32%
H: 1.53%
C: 1.1%
treatment lung cancer phase 1 results cancer
Becton, Dickinson and Company Announces Early Tender Results
Published: 2021-08-19 (Crawled : 11:00) - biospace.com/
BDX | $234.12 0.42% 0.0% 1.3M
|
Health Technology
|
| O: 0.23%
H: 0.53%
C: -0.4%
results
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.